ABSTRACTS from 16th International COnference on ... - CRRT Online
ABSTRACTS from 16th International COnference on ... - CRRT Online
ABSTRACTS from 16th International COnference on ... - CRRT Online
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<str<strong>on</strong>g>ABSTRACTS</str<strong>on</strong>g> FROM 17 TH INTERNATIONAL CONFERENCE ON <strong>CRRT</strong>,<br />
SAN DIEGO, FEB 14-17, 2012<br />
Although not statistically significant,<br />
there appears to be differences in<br />
NGAL, KIM-1, OPN and albumin at<br />
different days between those with AKI<br />
and those without AKI. C<strong>on</strong>clusi<strong>on</strong>s:<br />
Urinary biomarkers can predict AKI<br />
term ne<strong>on</strong>ates with perinatal depressi<strong>on</strong><br />
independent of gestati<strong>on</strong>al age.<br />
30. Preventi<strong>on</strong> of Acute Kidney Injury<br />
in Hospitalized Children with<br />
Cystic Fibrosis<br />
David Askenazi, Adam W Scott,<br />
LaCrecia J Britt<strong>on</strong>, Hector Gutierrez,<br />
Raym<strong>on</strong>d Lyrene<br />
University of Alabama at Birmingham<br />
Introducti<strong>on</strong>: Aminoglycosides (AGs)<br />
are comm<strong>on</strong>ly used to treat cystic<br />
fibrosis (CF) related lung infecti<strong>on</strong>s.<br />
AGs are nephrotoxic and are an<br />
important risk factor for acute kidney<br />
injury (AKI) in hospitalized CF patients.<br />
In June 29, a new clinical protocol was<br />
implemented to reduce the incidence of<br />
AKI by standardizing m<strong>on</strong>itoring and<br />
AG treatment in all CF patients admitted<br />
to Children’s Hospital of Alabama for<br />
pulm<strong>on</strong>ary exacerbati<strong>on</strong>s. Hypothesis:<br />
We hypothesized that the incidence of<br />
AKI in hospitalized children with CF<br />
would decrease after the implementati<strong>on</strong><br />
of this clinical protocol. Methods: A<br />
retrospective chart review was<br />
performed using data <str<strong>on</strong>g>from</str<strong>on</strong>g> the<br />
UAB/Children’s of Alabama’s Cystic<br />
Fibrosis Center database and hospital<br />
records for all admissi<strong>on</strong>s of CF patients<br />
with pulm<strong>on</strong>ary exacerbati<strong>on</strong>s <str<strong>on</strong>g>from</str<strong>on</strong>g> July<br />
27 to April 211.These data include<br />
demographics, co-morbidities, and<br />
serum creatinines (SCr). Hospitalized<br />
costs were obtained <str<strong>on</strong>g>from</str<strong>on</strong>g> the Children’s<br />
of Alabama for cost analysis. AKI was<br />
defined as a rise in SCr of .3 mg/dl or<br />
5% rise <str<strong>on</strong>g>from</str<strong>on</strong>g> a baseline value, according<br />
to the 211 Kidney Disease Improving<br />
Global Outcomes (KDIGO) AKI<br />
definiti<strong>on</strong>. Data analysis was performed<br />
using SPSS® software. IRB approval for<br />
the study was obtained. Results: The<br />
incidence of AKI was lower in the preprotocol<br />
group 96/ 631 (15.2%)<br />
compared to the post-protocol group<br />
113/ 475 (23.8%) (p